Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5280571
Max Phase: Preclinical
Molecular Formula: C41H65N5O18
Molecular Weight: 915.99
Associated Items:
ID: ALA5280571
Max Phase: Preclinical
Molecular Formula: C41H65N5O18
Molecular Weight: 915.99
Associated Items:
Canonical SMILES: CCCCCCCCCC[C@H](CC(=O)O[C@H]1CN(C)[C@@H](C(O[C@@H]2O[C@H](CN)[C@@H](O)[C@H]2O)[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)C(=O)N(C)[C@@H]1C(=O)O)OC(=O)C[C@H](C)CC(=O)O
Standard InChI: InChI=1S/C41H65N5O18/c1-5-6-7-8-9-10-11-12-13-22(60-27(50)17-21(2)16-26(48)49)18-28(51)61-24-20-44(3)30(37(56)45(4)29(24)39(57)58)35(64-40-34(55)31(52)23(19-42)62-40)36-32(53)33(54)38(63-36)46-15-14-25(47)43-41(46)59/h14-15,21-24,29-36,38,40,52-55H,5-13,16-20,42H2,1-4H3,(H,48,49)(H,57,58)(H,43,47,59)/t21-,22-,23-,24+,29+,30+,31-,32+,33-,34-,35?,36+,38-,40+/m1/s1
Standard InChI Key: VVLFISHNJLAURF-TVZWZLRASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 915.99 | Molecular Weight (Monoisotopic): 915.4325 | AlogP: -1.58 | #Rotatable Bonds: 24 |
Polar Surface Area: 340.24 | Molecular Species: ZWITTERION | HBA: 19 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.06 | CX Basic pKa: 8.75 | CX LogP: -4.78 | CX LogD: -5.46 |
Aromatic Rings: 1 | Heavy Atoms: 64 | QED Weighted: 0.04 | Np Likeness Score: 1.27 |
1. Serpi M, Ferrari V, Pertusati F.. (2016) Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?, 59 (23): [PMID:27607900] [10.1021/acs.jmedchem.6b00325] |
Source(1):